User profiles for Jessica J. Cunningham
Jessica J CunninghamFralin Biomedical Research Institute Verified email at vtc.vt.edu Cited by 1548 |
Integrating evolutionary dynamics into treatment of metastatic castrate-resistant prostate cancer
Abiraterone treats metastatic castrate-resistant prostate cancer by inhibiting CYP17A, an
enzyme for testosterone auto-production. With standard dosing, evolution of resistance with …
enzyme for testosterone auto-production. With standard dosing, evolution of resistance with …
Darwinian dynamics of intratumoral heterogeneity: not solely random mutations but also variable environmental selection forces
Spatial heterogeneity in tumors is generally thought to result from branching clonal evolution
driven by random mutations that accumulate during tumor development. However, this …
driven by random mutations that accumulate during tumor development. However, this …
Optimal control to develop therapeutic strategies for metastatic castrate resistant prostate cancer
JJ Cunningham, JS Brown, RA Gatenby… - Journal of theoretical …, 2018 - Elsevier
In metastatic castrate resistant prostate cancer (mCRPC), abiraterone is conventionally
administered continuously at maximal tolerated dose until treatment failure. The majority of …
administered continuously at maximal tolerated dose until treatment failure. The majority of …
Evolutionary dynamics in cancer therapy
JJ Cunningham, RA Gatenby… - Molecular …, 2011 - ACS Publications
Disseminated cancer remains a largely fatal disease. While systemic therapy can have some
initial success, it is rarely durable. Typically, populations of cancer cells resistant to therapy …
initial success, it is rarely durable. Typically, populations of cancer cells resistant to therapy …
Spatial vs. non-spatial eco-evolutionary dynamics in a tumor growth model
…, JJ Cunningham, RA Gatenby, J Zhang… - Journal of theoretical …, 2017 - Elsevier
Metastatic prostate cancer is initially treated with androgen deprivation therapy (ADT).
However, resistance typically develops in about 1 year – a clinical condition termed metastatic …
However, resistance typically develops in about 1 year – a clinical condition termed metastatic …
Frequency-dependent interactions determine outcome of competition between two breast cancer cell lines
Tumors are highly dynamic ecosystems in which diverse cancer cell subpopulations compete
for space and resources. These complex, often non-linear interactions govern continuous …
for space and resources. These complex, often non-linear interactions govern continuous …
A call for integrated metastatic management
JJ Cunningham - Nature ecology & evolution, 2019 - nature.com
… Jessica J. Cunningham … Cunningham, JJ A call for integrated metastatic management.
Nat Ecol Evol 3, 996–998 (2019). https://doi.org/10.1038/s41559-019-0927-x …
Nat Ecol Evol 3, 996–998 (2019). https://doi.org/10.1038/s41559-019-0927-x …
Coupled source-sink habitats produce spatial and temporal variation of cancer cell molecular properties as an alternative to branched clonal evolution and stem cell …
Intratumoral molecular cancer cell heterogeneity is conventionally ascribed to the accumulation
of random mutations that occasionally generate fitter phenotypes. This model is built …
of random mutations that occasionally generate fitter phenotypes. This model is built …
A phase 1b adaptive androgen deprivation therapy trial in metastatic castration sensitive prostate cancer
Simple Summary Despite early utilization of new hormonal agents (NHA, ie, abiraterone,
enzalutamide and apalutamide) for combined androgen deprivation therapy (ADT) for …
enzalutamide and apalutamide) for combined androgen deprivation therapy (ADT) for …
Aggregation effects and population-based dynamics as a source of therapy resistance in cancer
JS Brown, JJ Cunningham… - IEEE Transactions on …, 2016 - ieeexplore.ieee.org
Objective: Evolution of resistance allows cancer cells to adapt and continue proliferating even
when therapy is initially very effective. Most investigations of treatment resistance focus on …
when therapy is initially very effective. Most investigations of treatment resistance focus on …